Rate of improvement of CF life expectancy exceeds that of general population: observational death registration study

QR Code

Rate of improvement of CF life expectancy exceeds that of general population: observational death registration study

Background: It is unclear why cystic fibrosis (CF) survival has improved. We wished to quantify increases in CF median age of death in the context of general population survival improvement. Method: Death registration data analysis (US, England & Wales (E&W)—1972–2009). Results: CF median...

Full description

Bibliographic Details
Main Authors:	Hurley, Matthew, McKeeve, Tricia M., Prayle, Andrew P., Smyth, Alan R., Fogarty, Andrew W.
Format:	Article
Published:	Elsevier 2014
Subjects:	Cystic fibrosis; Survival; Mortality; Healthcare
Online Access:	https://eprints.nottingham.ac.uk/31674/

Similar Items

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Working with the patient and clinical community to deliver clinical research in cystic fibrosis. James Lind CF Phase II
by: Smith, S.J., et al.
Published: (2018)

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)

Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
by: Hutchinson, John P., et al.
Published: (2015)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century
by: Hutchinson, John P., et al.
Published: (2014)

Molecular mechanisms of enhanced expression of the chemokine interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial cells
by: Poghosyan, Anna
Published: (2014)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
by: Elborn, J. Stuart, et al.
Published: (2015)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
by: Flume, Patrick, et al.
Published: (2016)

High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)

Predicting 30-day mortality in patients with sepsis: an exploratory analysis of process of care and patient characteristics
by: Sanderson, Miriam, et al.
Published: (2018)

An evaluation of the High Frequency Digit Triplet Test as a screening tool for early detection of hearing loss in individuals with Cystic Fibrosis. Protocol v2.1.
by: Smyth, Alan R., et al.
Published: (2016)

Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
by: Hutchinson, John P., et al.
Published: (2016)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)

The effect of pulmonary rehabilitation on mortality, balance, and risk of fall in stable patients with chronic obstructive pulmonary disease: a systematic review
by: Hakamy, Ali, et al.
Published: (2017)

Understanding the Costs of Care for Cystic Fibrosis: an Analysis by Age and Health State
by: Van Gool, K., et al.
Published: (2013)

Effect of length of stay in intensive care unit on hospital and long-term mortality of critically ill adult patients
by: Williams, Teresa, et al.
Published: (2010)

Elucidating the interaction of CF airway epithelial cells and rhinovirus: Using the host-pathogen relationship to identify future therapeutic strategies
by: Ling, K.M., et al.
Published: (2018)

A systematic review to identify how the current clinical trials landscape reflects the James Lind Alliance top 10 research priorities for cystic fibrosis
by: Kalaitzis, I.S., et al.
Published: (2018)

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease
by: Hussein, Norita, et al.
Published: (2015)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Development of a transition readiness scale for young adults with cystic fibrosis: face and content validity
by: Dudman, Lauren, et al.
Published: (2011)

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
by: Delatycki, M., et al.
Published: (2014)

Development, implementation and evaluation of a nutrition education and behaviour program for children with cystc fibrosis.
by: Stapleton, Denise R.
Published: (2001)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.
by: Martinovich, K., et al.
Published: (2018)

Study of hyperpolarised 3He MRI diffusion on asthma and cystic fibrosis, and development of hyperpolarised 129Xe MRI lung imaging
by: Hardy, Steven M.
Published: (2016)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Expert: the curve of the pandemic is not flat, the number of deaths at the end of the month is expected to exceed the record
by: China Press
Published: (2021)

Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: The role of demographic and substance use characteristics
by: Lloyd, B., et al.
Published: (2013)

An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms
by: Harrison, Freya, et al.
Published: (2016)